Roth Capital's Joe Pantginis is one of the worst biotech analysts on the Street. i dont recall a single call this guy has gotten right. Roth is right up there with Rodman as one of the scumiest firms on the street.
Didnt Pantginis have a negative bias on Ariad, at Cannacord?
News 
Market Data 
Discover 
